Affiliation: Harvard Medical School and Beth Israel Deaconess Medical Center

Dr. Wang received his PhD degree from the University of Science and Technology of China in 2018, and his research focused on cancer metabolism and cell cycle regulation during this period. He joined BIDMC in 2018 and continued the research on targeting cancer metabolism for combinational therapy with immune components modulation. He is experienced in using different ways to detect metabolic changes in cancer cells.